Author:
de Lima Vinicius Araújo B.,Sørensen Jens Benn
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference25 articles.
1. Hillerdal G, et al. Treatment of malignant pleural mesothelioma with carboplatin, liposomized doxorubicin, and gemcitabine: a phase II study. J Thorac Oncol. 2008;3(11):1325–31.
2. Ellis P, Davis A, Evans WK, Haynes AE, Lloyd NS. Lung cancer disease site group of cancer care ontario’s program in evidence-based care. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline. Evidence-based series 7-14-1 Version 2. 2012.
3. Van Schil PE, et al. Multimodal management of malignant pleural mesothelioma: where are we today? Eur Respir J. 2014;44(3):754–64.
4. Papaspyros S, Papaspyros S. Surgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies. ISRN Surg. 2014;2014:817203.
5. Soerensen JB. Current concepts in chemotherapy for malignant pleural mesothelioma. Clin Respir J. 2008;2(2):74–9.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献